Jubilant Life Sciences – Q4, FY20 results
EBITDA was at Rs 1,555 Crore, up 13 per cent YoY with margin at 27.2 per cent, as compared with 25.7 per cent in FY19
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.